Related references
Note: Only part of the references are listed.Anti-programmed cell death-1 therapy and insulin-dependent diabetes: a case report
Juan Martin-Liberal et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Low programmed cell death-1 (PD-1) expression in peripheral CD4+ T cells in Japanese patients with autoimmune type 1 diabetes
R. Fujisawa et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Anti-PD-1 and Anti-PDL-1 Monoclonal Antibodies Causing Type 1 Diabetes
Mahnaz Mellati et al.
DIABETES CARE (2015)
Anti-PD1 Pembrolizumab Can Induce Exceptional Fulminant Type 1 Diabetes
Caroline Gaudy et al.
DIABETES CARE (2015)
Expression of PD-1 Molecule on Regulatory T Lymphocytes in Patients with Insulin-Dependent Diabetes Mellitus
Valentina Perri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Nivolumab: A Review of Its Use in Patients with Malignant Melanoma
Emma D. Deeks
DRUGS (2014)
Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset
Y. Kawabata et al.
DIABETOLOGIA (2009)
The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice
MJI Ansari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies.
A Imagawa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
